Additionally, Regal Partners reported net inflows of $80 million for the December quarter. This brings the total net inflows for 2025 to $1.5 billion. Management highlighted the strong performance ...

PWR Holdings has been awarded a $US9.1 million ($13.5 million) follow-on contract to supply advanced cooling solutions for a project undertaken by the US government. This new agre ...

Meanwhile, AustralianSuper, BlueScope’s largest shareholder with over 13 per cent of the company, has publicly supported BlueScope’s rejection of a $13.2 billion takeover offer. The offer was made by ...

Citi has reinstated its buy rating on AMP, anticipating the wealth manager will announce additional capital return measures concurrent with its FY25 results. Citi analyst Nigel Pittaway highlights ...

Coinbase Global is pressuring US legislators to preserve its ability to offer rewards to customers who hold stablecoins. The company views this offering as at risk if certain restrictions under ...

BPH Energy Ltd (ASX: BPH), an Australian company focused on investing in energy and biomedical technologies, has announced it has received binding commitments to raise approximately $1.2 million ...

High-Tech Metals Ltd (ASX: HTM), an Australian gold exploration and development company with a significant project portfolio in Western Australia, has announced encouraging initial assay results from ...

High-Tech Metals Ltd (ASX: HTM), an Australian gold exploration and development company focused on a significant gold project portfolio in Western Australia, has announced encouraging early assay ...

Jan 2026 - Nova Global Opportunities Fund PCC to invest in Findi's Indian subsidiary, TSI, bolstering long-term funding and growth platform ...

The system also cleanly separated all major rare earth oxides into individual products over a 24-minute cycle time, achieving a minimum 99.9% purity for each oxide. Brazilian Critical Minerals ...

In company news, Imricor secures first US FDA clearance for MRI-guided cardiac catheter Imricor Medical Systems (ASX:IMR) has received US Food and Drug Administration 510(k) clearance for its ...

The Australian sharemarket is poised for another year of solid, but unspectacular returns in 2026. After underperforming most ...